188 related articles for article (PubMed ID: 19275612)
41. Antineoplastic activity of isoliquiritigenin, a chalcone compound, in androgen-independent human prostate cancer cells linked to G2/M cell cycle arrest and cell apoptosis.
Zhang B; Lai Y; Li Y; Shu N; Wang Z; Wang Y; Li Y; Chen Z
Eur J Pharmacol; 2018 Feb; 821():57-67. PubMed ID: 29277717
[TBL] [Abstract][Full Text] [Related]
42. (Iso)flav(an)ones, chalcones, catechins, and theaflavins as anticarcinogens: mechanisms, anti-multidrug resistance and QSAR studies.
Mercader AG; Pomilio AB
Curr Med Chem; 2012; 19(25):4324-47. PubMed ID: 22830339
[TBL] [Abstract][Full Text] [Related]
43. Solid-phase synthesis of 2'-hydroxychalcones. Effects on cell growth inhibition, cell cycle and apoptosis of human tumor cell lines.
Neves MP; Cravo S; Lima RT; Vasconcelos MH; Nascimento MS; Silva AM; Pinto M; Cidade H; Corrêa AG
Bioorg Med Chem; 2012 Jan; 20(1):25-33. PubMed ID: 22177409
[TBL] [Abstract][Full Text] [Related]
44. Chalcones: Potential Chemotherapeutic Compounds and Educational Tools for Closing the Loop in STEM.
Russell AE; Gines BR
Acc Chem Res; 2023 Jun; 56(11):1256-1262. PubMed ID: 36696370
[TBL] [Abstract][Full Text] [Related]
45. Functional evaluation of synthetic flavonoids and chalcones for potential antiviral and anticancer properties.
Mateeva N; Eyunni SVK; Redda KK; Ononuju U; Hansberry TD; Aikens C; Nag A
Bioorg Med Chem Lett; 2017 Jun; 27(11):2350-2356. PubMed ID: 28442256
[TBL] [Abstract][Full Text] [Related]
46. Licochalcone A inhibits growth of gastric cancer cells by arresting cell cycle progression and inducing apoptosis.
Xiao XY; Hao M; Yang XY; Ba Q; Li M; Ni SJ; Wang LS; Du X
Cancer Lett; 2011 Mar; 302(1):69-75. PubMed ID: 21216524
[TBL] [Abstract][Full Text] [Related]
47. Chalcones against the hallmarks of cancer: a mini-review.
de Souza PS; Bibá GCC; Melo EDDN; Muzitano MF
Nat Prod Res; 2022 Sep; 36(18):4809-4826. PubMed ID: 34865580
[TBL] [Abstract][Full Text] [Related]
48. Synthesis and biological evaluation of a series of tangeretin-derived chalcones.
Quintin J; Desrivot J; Thoret S; Le Menez P; Cresteil T; Lewin G
Bioorg Med Chem Lett; 2009 Jan; 19(1):167-9. PubMed ID: 19013795
[TBL] [Abstract][Full Text] [Related]
49. Flavonoids: recent advances as anticancer drugs.
Liu HL; Jiang WB; Xie MX
Recent Pat Anticancer Drug Discov; 2010 Jun; 5(2):152-64. PubMed ID: 20088766
[TBL] [Abstract][Full Text] [Related]
50. Design, synthesis, and biological evaluation of thiophene analogues of chalcones.
Romagnoli R; Baraldi PG; Carrion MD; Cara CL; Cruz-Lopez O; Preti D; Tolomeo M; Grimaudo S; Di Cristina A; Zonta N; Balzarini J; Brancale A; Sarkar T; Hamel E
Bioorg Med Chem; 2008 May; 16(10):5367-76. PubMed ID: 18440234
[TBL] [Abstract][Full Text] [Related]
51. Synthesis and identification of α-cyano bis(indolyl)chalcones as novel anticancer agents.
Kumar D; Maruthi Kumar N; Tantak MP; Ogura M; Kusaka E; Ito T
Bioorg Med Chem Lett; 2014 Nov; 24(22):5170-4. PubMed ID: 25442306
[TBL] [Abstract][Full Text] [Related]
52. Advances in chalcones with anticancer activities.
Karthikeyan C; Moorthy NS; Ramasamy S; Vanam U; Manivannan E; Karunagaran D; Trivedi P
Recent Pat Anticancer Drug Discov; 2015; 10(1):97-115. PubMed ID: 25138130
[TBL] [Abstract][Full Text] [Related]
53. Synthesis and cytotoxic activities of some pyrazoline derivatives bearing phenyl pyridazine core as new apoptosis inducers.
George RF; Fouad MA; Gomaa IEO
Eur J Med Chem; 2016 Apr; 112():48-59. PubMed ID: 26874744
[TBL] [Abstract][Full Text] [Related]
54. A novel chalcone derivative, LQFM064, induces breast cancer cells death via p53, p21, KIT and PDGFRA.
Cabral BLS; da Silva ACG; de Ávila RI; Cortez AP; Luzin RM; Lião LM; de Souza Gil E; Sanz G; Vaz BG; Sabino JR; Menegatti R; Valadares MC
Eur J Pharm Sci; 2017 Sep; 107():1-15. PubMed ID: 28627468
[TBL] [Abstract][Full Text] [Related]
55. Synthesis, anticancer activity and effects on cell cycle profile and apoptosis of novel thieno[2,3-d]pyrimidine and thieno[3,2-e] triazolo[4,3-c]pyrimidine derivatives.
Kandeel MM; Refaat HM; Kassab AE; Shahin IG; Abdelghany TM
Eur J Med Chem; 2015 Jan; 90():620-32. PubMed ID: 25499930
[TBL] [Abstract][Full Text] [Related]
56. Design, Synthesis, and Evaluation of (2-(Pyridinyl)methylene)-1-tetralone Chalcones for Anticancer and Antimicrobial Activity.
Gibson MZ; Nguyen MA; Zingales SK
Med Chem; 2018; 14(4):333-343. PubMed ID: 29065840
[TBL] [Abstract][Full Text] [Related]
57. Review in quantitative structure activity relationships on lipoxygenase inhibitors.
Eleni P; Dimitra HL
Mini Rev Med Chem; 2003 Aug; 3(5):487-99. PubMed ID: 12769699
[TBL] [Abstract][Full Text] [Related]
58. Induction of apoptosis and cell cycle arrest by a chalcone panduratin A isolated from Kaempferia pandurata in androgen-independent human prostate cancer cells PC3 and DU145.
Yun JM; Kweon MH; Kwon H; Hwang JK; Mukhtar H
Carcinogenesis; 2006 Jul; 27(7):1454-64. PubMed ID: 16497706
[TBL] [Abstract][Full Text] [Related]
59. Induction of cell cycle arrest in prostate cancer cells by the dietary compound isoliquiritigenin.
Lee YM; Lim DY; Choi HJ; Jung JI; Chung WY; Park JH
J Med Food; 2009 Feb; 12(1):8-14. PubMed ID: 19298190
[TBL] [Abstract][Full Text] [Related]
60. Synthesis and biological evaluation of 2',5'-dimethoxychalcone derivatives as microtubule-targeted anticancer agents.
Tu HY; Huang AM; Hour TC; Yang SC; Pu YS; Lin CN
Bioorg Med Chem; 2010 Mar; 18(6):2089-2098. PubMed ID: 20199865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
